Business
Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025
SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted how optical genome mapping (OGM) can enhance the detection of structural variants (SVs) with greater clarity and sensitivity than traditional cytogenetic and molecular techniques. Through platform presentations and poster sessions, multiple researchers emp
About this update from Bionano Genomics, Inc.
[{"type":"image","alt":"Bionano Genomics","displaySize":"","headline":null,"caption":"Bionano Genomics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/b39fec01655bcf34db9e215be03042b1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ylN8_Gs3_qAPxed5dOQIGw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/b39fec01655bcf34db9e215be03042b1","width":300,"height":61}},"lazy":false},{"type":"text","content":"SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted how optical genome mapping (OGM) can enhance the detection of structural variants (SVs) with greater clarity and sensitivity than traditional cytogenetic and molecular techniques. Through platform presentations and poster sessions, multiple researchers emphasized the expanding utility of OGM in inherited disease testing, reproductive disorders, hematological malignancies, and solid tumors.","length":636,"tagName":"p"},{"type":"text","content":"Key Highlights from AMP 2025:","length":29,"tagName":"p"},{"type":"text","content":"A total of thirteen studies, noted below, highlighted the increasing use of OGM and its capacity to detect novel and clinically relevant structural variants, either independently or complementary to other molecular and cytogenetic methods. When taken together, these results demonstrate OGM’s potential strength as a high-resolution, genome-wide technique for uncovering genetic mechanisms that drive complex diseases.","length":418,"tagName":"p"},{"type":"text","content":"Researchers also presented data showing streamlined laboratory workflows and successful integration of OGM into existing cytogenetics and next-generation sequencing (NGS) pipelines, reinforcing its utility in both clinical and translational research settings.","length":259,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Utility of Optical Genome Mapping in a Case of Recurrent Pregnancy Loss – Amira Othman, Queens University, Canada","length":114,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Comprehensive Molecular Profiling of Pediatric Low-Grade G...